Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis

Molecular Therapy

Volumn 20, Issue 10, 2012, Pages 1932-1943

  Barese, Cecilia N ^a   Krouse, Allen E ^a   Metzger, Mark E ^a   King, Connor A ^a   Traversari, Catia ^b   Marini, Frank C ^c,d   Donahue, Robert E ^a   Dunbar, Cynthia E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b MOLMED S P A   (Italy)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GANCICLOVIR; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOTRANSPLANTATION; CONTROLLED STUDY; DRUG DOSE ESCALATION; ENGRAFTMENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HERPES SIMPLEX; HUMAN; HUMAN CELL; IN VIVO STUDY; MULTIPLE CYCLE TREATMENT; NONHUMAN; SINGLE DRUG DOSE; SUICIDE GENE; VIRAL GENE DELIVERY SYSTEM;

MACACA MULATTA; SIMPLEXVIRUS;

EID: 84866989041     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.166     Document Type: Article

References (51)

1. Cavazzana-Calvo, M, Hacein-Bey, S, de Saint Basile, G, Gross, F, Yvon, E, Nusbaum, P et al. (2000). Gene therapy of human severe combined immunodefciency (SCID)-X1 disease. Science 288: 669-672.
2. Ott, MG, Schmidt, M, Schwarzwaelder, K, Stein, S, Siler, U, Koehl, U et al. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat Med 12: 401-409.
3. Aiuti, A, Cattaneo, F, Galimberti, S, Benninghoff, U, Cassani, B, Callegaro, L et al. (2009). Gene therapy for immunodefciency due to adenosine deaminase defciency. N Engl J Med 360: 447-458.
4. Cartier, N, Hacein-Bey-Abina, S, Bartholomae, CC, Veres, G, Schmidt, M, Kutschera, I et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823.
5. Cavazzana-Calvo, M, Payen, E, Negre, O, Wang, G, Hehir, K, Fusil, F et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human ß-thalassaemia. Nature 467: 318-322.
6. Gaspar, HB, Cooray, S, Gilmour, KC, Parsley, KL, Zhang, F, Adams, S et al. (2011). Hematopoietic stem cell gene therapy for adenosine deaminase-defcient severe combined immunodefciency leads to long-term immunological recovery and metabolic correction. Sci Transl Med 3: 97ra80.
7. Gaspar, HB, Cooray, S, Gilmour, KC, Parsley, KL, Adams, S, Howe, SJet al. (2011) Longterm persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodefciency. Sci Transl Med; 3: 97ra79.
8. Li, Z, Düllmann, J, Schiedlmeier, B, Schmidt, M, von Kalle, C, Meyer, J et al. (2002). Murine leukemia induced by retroviral gene marking. Science 296: 497.
9. Hacein-Bey-Abina, S, Von Kalle, C, Schmidt, M, McCormack, MP, Wulffraat, N, Leboulch, P et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
10. Modlich, U, Kustikova, OS, Schmidt, M, Rudolph, C, Meyer, J, Li, Z et al. (2005). Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. Blood 105: 4235-4246.
11. Kustikova, O, Fehse, B, Modlich, U, Yang, M, Düllmann, J, Kamino, K et al. (2005). Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308: 1171-1174.
12. Hacein-Bey-Abina, S, Garrigue, A, Wang, G P, Soulier, J, Lim, A, Morillon, E et al. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118: 3132-3142.
13. Howe, SJ, Mansour, MR, Schwarzwaelder, K, Bartholomae, C, Hubank, M, Kempski, H et al. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118: 3143-3150.
14. Boztug, K, Schmidt, M, Schwarzer, A, Banerjee, P P, Díez, IA, Dewey, RA et al. (2010). Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med 363: 1918-1927.
15. Modlich, U, Navarro, S, Zychlinski, D, Maetzig, T, Knoess, S, Brugman, MH et al. (2009). Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 17: 1919-1928.
16. Yannaki, E, Tubb, J, Aker, M, Stamatoyannopoulos, G and Emery, DW (2002). Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors. Mol Ther 5(5 Pt 1): 589-598.
17. Ramezani, A, Hawley, TS and Hawley, RG (2008). Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential. Stem Cells 26: 3257-3266.
18. Bauer, TR Jr, Olson, EM, Huo, Y, Tuschong, LM, Allen, JM, Li, Y et al. (2011). Treatment of canine leukocyte adhesion defciency by foamy virus vectors expressing CD18 from a PGK promoter. Gene Ther 18: 553-559.
19. Hu, J, Renaud, G, Gomes, TJ, Golmes, T, Ferris, A, Hendrie, PC et al. (2008). Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors. Mol Ther 16: 1617-1623.
20. Lombardo, A, Cesana, D, Genovese, P, Di Stefano, B, Provasi, E, Colombo, DF et al. (2011). Site-specifc integration and tailoring of cassette design for sustainable gene transfer. Nat Methods 8: 861-869.
21. Trobridge, GD (2011). Genotoxicity of retroviral hematopoietic stem cell gene therapy. Expert Opin Biol Ther 11: 581-593.
22. Bonini, C, Bondanza, A, Perna, SK, Kaneko, S, Traversari, C, Ciceri, F et al. (2007). The suicide gene therapy challenge: how to improve a successful gene therapy approach. Mol Ther 15: 1248-1252.
23. Shalev, M, Kadmon, D, Teh, BS, Butler, EB, Aguilar-Cordova, E, Thompson, TC et al. (2000). Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer. J Urol 163: 1747-1750.
24. Immonen, A, Vapalahti, M, Tyynelä, K, Hurskainen, H, Sandmair, A, Vanninen, R et al. (2004). AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 10: 967-972.
25. Bonini, C, Ferrari, G, Verzeletti, S, Servida, P, Zappone, E, Ruggieri, L et al. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276: 1719-1724.
26. Ciceri, F, Bonini, C, Stanghellini, MT, Bondanza, A, Traversari, C, Salomoni, M et al. (2009). Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. Lancet Oncol 10: 489-500.
27. Russo, V, Bondanza, A, Ciceri, F, Bregni, M, Bordignon, C, Traversari, C et al. (2012). A dual role for genetically modifed lymphocytes in cancer immunotherapy. Trends Mol Med 18: 193-200.
28. Rainov, NG (2000). A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11: 2389-2401.
29. Fareed, MU and Moolten, FL (2002). Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand-a fail-safe protection against cellular misbehavior. Gene Ther 9: 955-962.
30. Menzel, O, Birraux, J, Wildhaber, BE, Jond, C, Lasne, F, Habre, W et al. (2009). Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates. Mol Ther 17: 1754-1760.
31. Jung, J, Hackett, NR, Pergolizzi, RG, Pierre-Destine, L, Krause, A and Crystal, RG (2007). Ablation of tumor-derived stem cells transplanted to the central nervous system by genetic modifcation of embryonic stem cells with a suicide gene. Hum Gene Ther 18: 1182-1192.
32. Newrzela, S, Cornils, K, Li, Z, Baum, C, Brugman, MH, Hartmann, M et al. (2008). Resistance of mature T cells to oncogene transformation. Blood 112: 2278-2286.
33. Dotti, G, Tian, M, Savoldo, B, Najjar, A, Cooper, LJ, Jackson, J et al. (2009). Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU. Mol Imaging 8: 230-237.
34. Dilber, MS, Abedi, MR, Björkstrand, B, Christensson, B, Gahrton, G, Xanthopoulos, KG et al. (1996). Suicide gene therapy for plasma cell tumors. Blood 88: 2192-2200.
35. rd and Kornblau, SM (1999). Production and culture of HSVtk transduced suicidal lymphocytes induces variable changes in the lymphocyte subset composition. Bone Marrow Transplant 23: 907-915.
36. Garin, MI, Garrett, E, Tiberghien, P, Apperley, JF, Chalmers, D, Melo, JV et al. (2001). Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene. Blood 97: 122-129.
37. Black, ME, Kokoris, MS and Sabo, P (2001). Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Cancer Res 61: 3022-3026.
38. Kokoris, MS and Black, ME (2002). Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity. Protein Sci 11: 2267-2272.
39. Dykhuizen, M, Ceman, J, Mitchen, J, Zayas, M, MacDougall, A, Helgeland, J et al. (2000). Importance of the CD3 marker for evaluating changes in rhesus macaque CD4/CD8 T-cell ratios. Cytometry 40: 69-75.
40. Heim, DA, Hanazono, Y, Giri, N, Wu, T, Childs, R, Sellers, SE et al. (2000). Introduction of a xenogeneic gene via hematopoietic stem cells leads to specifc tolerance in a rhesus monkey model. Mol Ther 1: 533-544.
41. Kung, SK, An, DS, Bonifacino, A, Metzger, ME, Ringpis, GE, Mao, SH et al. (2003). Induction of transgene-specifc immunological tolerance in myeloablated nonhuman primates using lentivirally transduced CD34+ progenitor cells. Mol Ther 8: 981-991.
42. Verzeletti, S, Bonini, C, Marktel, S, Nobili, N, Ciceri, F, Traversari, C et al. (1998). Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum Gene Ther 9: 2243-2251.
43. Herraiz, M, Beraza, N, Solano, A, Sangro, B, Montoya, J, Qian, C et al. (2003). Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion. Hum Gene Ther 14: 463-472.
44. Schmidt, M, Zickler, P, Hoffmann, G, Haas, S, Wissler, M, Muessig, A et al. (2002). Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100: 2737-2743.
45. Schmidt, M, Carbonaro, DA, Speckmann, C, Wissler, M, Bohnsack, J, Elder, M et al. (2003). Clonality analysis after retroviral-mediated gene transfer to CD34 cells from the cord blood of ADA-defcient SCID neonates. Nat Med 9: 463-468.
46. Thornhill, SI, Schambach, A, Howe, SJ, Ulaganathan, M, Grassman, E, Williams, D et al. (2008). Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodefciency. Mol Ther 16: 590-598.
47. Zhou, S, Mody, D, DeRavin, SS, Hauer, J, Lu, T, Ma, Z et al. (2010). A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells. Blood 116: 900-908.
48. Frank, O, Rudolph, C, Heberlein, C, von Neuhoff, N, Schröck, E, Schambach, A et al. (2004). Tumor cells escape suicide gene therapy by genetic and epigenetic instability. Blood 104: 3543-3549.
49. Di Stasi, A, Tey, SK, Dotti, G, Fujita, Y, Kennedy-Nasser, A, Martinez, C et al. (2011). Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med 365: 1673-1683.
50. Donahue, RE, Kuramoto, K and Dunbar, CE (2005). Large animal models for stem and progenitor cell analysis. Curr Protoc Immunol Chapter 22: Unit 22A.1.
51. Qasim, W, Thrasher, AJ, Buddle, J, Kinnon, C, Black, ME and Gaspar, HB (2002). T cell transduction and suicide with an enhanced mutant thymidine kinase. Gene Ther 9: 824-827.